BioCardia, Inc. Revenue Breakdown
No Revenue Breakdown for BCDA on this site yet.
- 2017-12-31: Total revenue $479.00K.
- 2016-12-31: Others Not split by product in the filing$576.00K100.00%; Total revenue $576.00K.
- 2015-12-31: Others Not split by product in the filing$904.00K100.00%; Total revenue $904.00K.
- 2011-12-31: Total revenue $12.00K.
Source checked: the stored Revenue Breakdown page for BCDA.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2017-12-31 | $479.00K | |
| 2016-12-31 | Not split by product in the filing $576.00K 100.00% | $576.00K |
| 2015-12-31 | Not split by product in the filing $904.00K 100.00% | $904.00K |
| 2011-12-31 | $12.00K | |
| 2010-12-31 | $0.00 |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2017-12-31 | Not split by product $100.00K 100.00% | $100.00K |
| 2017-09-30 | Not split by product $130.00K 100.00% | $130.00K |
| 2017-06-30 | Not split by product $112.00K 100.00% | $112.00K |
| 2017-03-31 | Not split by product $137.00K 100.00% | $137.00K |
| 2016-12-31 | Not split by product $137.00K 100.00% | $137.00K |
| 2016-09-30 | Not split by product $117.00K 100.00% | $117.00K |
| 2016-06-30 | Not split by product $144.00K 100.00% | $144.00K |
| 2016-03-31 | Not split by product $178.00K 100.00% | $178.00K |
| 2012-09-30 | Not split by product $19.00K 100.00% | $19.00K |
| 2012-06-30 | Not split by product $17.00K 100.00% | $17.00K |
| 2012-03-31 | Not split by product $11.00K 100.00% | $11.00K |
| 2011-12-31 | Not split by product $12.00K 100.00% | $12.00K |
| 2011-09-30 | Not split by product $0.00 | $0.00 |
| 2011-06-30 | Not split by product $0.00 | $0.00 |
| 2011-03-31 | Not split by product $0.00 | $0.00 |
| 2010-12-31 | Not split by product $0.00 | $0.00 |
| 2010-09-30 | Not split by product $0.00 | $0.00 |
| 2010-06-30 | Not split by product $0.00 | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |